Navigating the Complex, Uncertain Regulatory Environment to Expedite Global Patient Access to Liquid Biopsy Testing
- How to drive global approvals – and expedited approvals – for liquid biopsies
- Understanding evolving global regulatory landscape and call for harmonization
- Emphasizing the importance of early regulatory considerations in clinical studies